Local bacteria affect the efficacy of chemotherapeutic drugs

Activation of the anticancer drugs cyclophosphamide and ifosfamide by cytochrome P450 BM3 mutants

(2015) Galvin Vredenburg et al.   TOXICOLOGY LETTERS

Microbiota of Human Breast Tissue

(2014) Camilla Urbaniak et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

Investigating the contribution of CYP2J2 to ritonavir metabolism in vitro and in vivo

(2014) Rüdiger Kaspera et al.   BIOCHEMICAL PHARMACOLOGY

Pancreatic Cancer, Inflammation, and Microbiome

(2014) Constantinos P. Zambirinis et al.   CANCER JOURNAL

Gut microbiome and anticancer immune response: really hot Sh*t!

(2014) S Viaud et al.   CELL DEATH AND DIFFERENTIATION

Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome

(2014) L. Flanagan et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Effect of oral cladribine on time to conversion to clinically definite multiple sclerosis in patients with a first demyelinating event (ORACLE MS): a phase 3 randomised trial

(2014) Thomas P Leist et al.   LANCET NEUROLOGY

Bloodstream Infections in Patients With Solid Tumors

(2014) Mar Marín et al.   MEDICINE

Microbial Dysbiosis Is Associated with Human Breast Cancer

(2014) Caiyun Xuan et al.   PLoS One

The Placenta Harbors a Unique Microbiome

(2014) K. Aagaard et al.   Science Translational Medicine

Intratumoral injection of Clostridium novyi-NT spores induces antitumor responses

(2014) N. J. Roberts et al.   Science Translational Medicine

Helicobacter pyloriinfection: New pathogenetic and clinical aspects

(2014) Krisztina Hagymási   WORLD JOURNAL OF GASTROENTEROLOGY

Use of bacillus Calmette–Guérin in stage T1 bladder cancer: Long-term observation of a population-based cohort

(2014) Oliver Patschan et al.   Scandinavian Journal of Urology

Clostridium difficile infection in hospitalized cancer patients in Beijing, China is facilitated by receipt of cancer chemotherapy

(2013) X.H. Han et al.   ANAEROBE

Older and new purine nucleoside analogs for patients with acute leukemias

(2013) Pawel Robak et al.   CANCER TREATMENT REVIEWS

Colonization of the Human Gut by E. coli and Colorectal Cancer Risk

(2013) M. Bonnet et al.   CLINICAL CANCER RESEARCH

SWOG S0353: Phase II Trial of Intravesical Gemcitabine in Patients with Nonmuscle Invasive Bladder Cancer and Recurrence after 2 Prior Courses of Intravesical Bacillus Calmette-Guérin

(2013) Eila C. Skinner et al.   JOURNAL OF UROLOGY

Fusobacterium Is Associated with Colorectal Adenomas

(2013) Amber N. McCoy et al.   PLoS One

The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide

(2013) S. Viaud et al.   SCIENCE

Bacteria and tumours: causative agents or opportunistic inhabitants?

(2013) Joanne Cummins et al.   Infectious Agents and Cancer

Tumor-targeting Salmonella typhimurium, a natural tool for activation of prodrug 6MePdR and their combination therapy in murine melanoma model

(2012) Guo Chen et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

Intravesical chemotherapy plus bacille Calmette-Guérin in non-muscle invasive bladder cancer: a systematic review with meta-analysis

(2012) Baerin B. Houghton et al.   BJU INTERNATIONAL

In vivo antitumor activity of intratumoral fludarabine phosphate in refractory tumors expressing E. coli purine nucleoside phosphorylase

(2012) Eric J. Sorscher et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Bacterial Inactivation of the Anticancer Drug Doxorubicin

(2012) Erin L. Westman et al.   CHEMISTRY & BIOLOGY

Structure, function and diversity of the healthy human microbiome

(2012)   NATURE

Developing a metagenomic view of xenobiotic metabolism

(2012) Henry J. Haiser et al.   PHARMACOLOGICAL RESEARCH

High Resolution In Vivo Bioluminescent Imaging for the Study of Bacterial Tumour Targeting

(2012) Michelle Cronin et al.   PLoS One

Is It Time for a Metagenomic Basis of Therapeutics?

(2012) H. J. Haiser et al.   SCIENCE

Study of the role played by NfsA, NfsB nitroreductase and NemA flavin reductase from Escherichia coli in the conversion of ethyl 2-(2′-nitrophenoxy)acetate to 4-hydroxy-(2H)-1,4-benzoxazin-3(4H)-one (D-DIBOA), a benzohydroxamic acid with interesting biological properties

(2011) Antonio Valle et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

Analysis of heterologous taxadiene production in K- and B-derived Escherichia coli

(2011) Brett A. Boghigian et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

Biotransformation of 4-chloro-2-nitrophenol into 5-chloro-2-methylbenzoxazole by a marine Bacillus sp. strain MW-1

(2011) Pankaj Kumar Arora et al.   BIODEGRADATION

Enhanced efficiency of prodrug activation therapy by tumor-selective replicating retrovirus vectors armed with the Escherichia coli purine nucleoside phosphorylase gene

(2010) C-K Tai et al.   CANCER GENE THERAPY

Tumour Targeting with Systemically Administered Bacteria

(2010) David Morrissey et al.   CURRENT GENE THERAPY

Listeria monocytogenes as a Vector for Anti-Cancer Therapies

(2010) Mark Tangney et al.   CURRENT GENE THERAPY

Orally Administered Bifidobacteria as Vehicles for Delivery of Agents to Systemic Tumors

(2010) Michelle Cronin et al.   MOLECULAR THERAPY

Prostate Stem Cell Antigen DNA Vaccination Breaks Tolerance to Self-antigen and Inhibits Prostate Cancer Growth

(2009) Sarfraz Ahmad et al.   MOLECULAR THERAPY

The gastrointestinal microbiota as a site for the biotransformation of drugs

(2008) Tiago Sousa et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS